by Hanna | Jan 15, 2025 | Blog Post
For many early-stage life sciences companies, mergers and acquisitions (M&A) and other collaborations are fundamental to advancing promising new discoveries. An acquisition by a larger, more established company often represents a necessary and anticipated...
by Hanna | Dec 18, 2024 | Blog Post
A recent report from BIO and TEConomy notes that decades of growth in the life sciences have been “rooted in, and enabled by, basic and applied research and development activities; development of, and access to, a qualified and highly skilled workforce; [and]...
by Hanna | Dec 12, 2024 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Hanna | Dec 5, 2024 | Blog Post, PULSE Partner
In a recent op-ed for the Detroit News, Stephen Rapundalo, President and CEO of PULSE Partner MichBio, highlights the vital role of mergers and acquisitions (M&A) in fueling innovation and competition across Michigan’s life sciences ecosystem. As Rapundalo...
by Hanna | Dec 4, 2024 | Blog Post
The culmination of flawed antitrust policies by the Federal Trade Commission (FTC) and Department of Justice (DOJ) have discouraged pro-competitive mergers that could meaningfully benefit American consumers – a growing concern raised by former FTC general counsel and...
by Hanna | Nov 19, 2024 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this...
by Hanna | Nov 13, 2024 | Blog Post, PULSE Partner
In a recent blog post, PULSE partner Colorado Bioscience Association (CBSA) highlighted the fundamental role of pro-innovation mergers and acquisitions in driving life sciences innovation and economic growth in Colorado and beyond. Read their blog post below: In...
by Hanna | Nov 7, 2024 | Blog Post
The Federal Trade Commission (FTC)’s recently finalized Hart-Scott-Rodino (HSR) premerger notification rule places a significant time and cost burden on companies engaging in pro-competitive mergers and acquisitions (M&A), according to top legal analyses and the...
by Hanna | Oct 30, 2024 | Blog Post
The Federal Trade Commission (FTC)’s aggressive approach to mergers and acquisitions enforcement (M&A) is disrupting critical investment in innovation, according to National Venture Capital Association (NVCA) President Bobby Franklin, in an interview with Axios....
by Hanna | Oct 15, 2024 | Blog Post, PULSE Partner
Leading organizations are expressing concern about the impact of the Federal Trade Commission (FTC)’s final Hart-Scott-Rodino (HSR) premerger notification rule, including the chilling effect it could have on biopharmaceutical and life sciences innovation. While the...
